 Clinical correlation serum-soluble receptor levels Guillain-Barre syndrome patients Guillain-Barre syndrome GBS soluble receptor levels patients neurologic diseases OND healthy controls Smaller increases levels OND patients healthy subjects Monitoring GBS patients decreases levels clinical recovery T-cell activation relevant pathogenesis GBS